Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography

Nucl Med Biol. 2000 Jan;27(1):33-41. doi: 10.1016/s0969-8051(99)00085-2.

Abstract

In three patients with carcinoid liver and/or lymph node metastases, we studied the process of tumor tracer uptake and decarboxylation by means of positron emission tomography (PET) using 5-hydroxy-L-tryptophan (5-HTP) 11C-labeled in the beta-position (HTP) and later the same day with 5-HTP 11C-labeled in the carboxyl group (HTC). With HTP, in which the 11C-label follows the molecule through decarboxylation to form 11C-serotonin, a high tumor accumulation of the tracer was found. With HTC, in which the label is rapidly eliminated from the tissues as 11CO2 if decarboxylation takes place, there was virtually no uptake by the tumors. By utilizing data from PET scanning with both tracers, we could quantify the decarboxylation rate and tissue accumulation of [11C]-serotonin and hence the enzymatic action of aromatic amino acid decarboxylase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5-Hydroxytryptophan / metabolism
  • 5-Hydroxytryptophan / pharmacokinetics*
  • Antineoplastic Agents / therapeutic use
  • Carbon Radioisotopes
  • Carcinoid Tumor / diagnostic imaging
  • Carcinoid Tumor / metabolism*
  • Decarboxylation
  • Female
  • Gastrointestinal Neoplasms / diagnostic imaging
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / metabolism*
  • Humans
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / metabolism*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Regression Analysis
  • Tomography, Emission-Computed*

Substances

  • Antineoplastic Agents
  • Carbon Radioisotopes
  • 5-Hydroxytryptophan